About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Clinical Diagnostics Market Outlook Report 2025-2030 | Agile Investment in AI and Emerging Markets Key to Sustained Growth in Diagnostics - ResearchAndMarkets.com

The "Clinical Diagnostics Outlook, 2025" report has been added to ResearchAndMarkets.com's offering.

This research service provides a global outlook for the clinical diagnostics market, along with a 5-year revenue forecast from 2025 to 2030.

To succeed in 2025 and beyond, companies must act with agility, invest in high-value areas, and prioritize innovation. Those that adopt AI, expand decentralized testing, and enter emerging markets will be best positioned for sustained growth.

The market analysis covers three core segments. Centralized Testing includes clinical chemistry and immunoassays (CC&IA), hematology, hemostasis, and molecular diagnostics, with detailed coverage of CC&IA and molecular diagnostics. Referral and Peripheral Testing comprises tissue diagnostics and clinical microbiology, with in-depth insights into tissue diagnostics. Decentralized Testing encompasses point-of-care testing (POCT) and self-monitoring blood glucose (SMBG), with a strong focus on the POCT segment.

The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive market momentum. The growing elderly population continues to drive demand for chronic disease testing. At the same time, advances in technology are opening new possibilities in genetic and biomarker testing, allowing stakeholders to prioritize personalized medicine - particularly in developing countries that are investing heavily in clinical diagnostics and healthcare infrastructure.

Innovators are increasingly defining the landscape through software-based solutions and broader product portfolios. Developers of liquid biopsy technologies have transformed oncology diagnostics by enabling the non-invasive detection of circulating tumor cells and cell-free DNA. This shift has intensified competition between traditional tissue biopsy providers and molecular diagnostics firms.

The growing adoption of liquid biopsy tests, such as Delfi Diagnostics' FirstLook Lung (LDT) and Guardant Health's Shield blood test for early colorectal cancer detection, reflects this transition toward personalized, non-invasive diagnostics. Pharmaceutical companies are driving this trend by investing in biomarker-based tests, which position oncology and rare disease diagnostics as key growth areas. Continued progress in precision medicine and molecular diagnostics enhances the accuracy and scalability of predictive testing.

Asia-Pacific (APAC) continues to drive the market's fastest growth. Analysts project double-digit sales increases in 2025, as countries like India and China adopt digital pathology and affordable molecular diagnostics at scale. Companies such as MGI Tech are meeting this demand by launching automated next-generation sequencing (NGS) solutions to expand diagnostic access. In collaboration with Universidad de San Martin de Porres, MGI also strengthens genetic research by applying NGS to identify genetic risk factors that support future public health initiatives. Across these markets, government-led healthcare reforms are enabling long-term industry expansion.

Meanwhile, large companies continue to find substantial opportunities in the United States. Industry leaders are accelerating consolidation by acquiring niche technology providers to enhance their portfolios. For example, Danaher strengthened its protein research and diagnostics capabilities by acquiring Abcam. This integration contributed to a 10% revenue increase over 2024 by incorporating innovative products into existing offerings.

Key Topics Covered:

Analysis Highlights

  • The 2024 Clinical Diagnostics Industry: Forecast vs. Actual
  • Historical Analytics
  • Top Clinical Diagnostics Predictions for 2025

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative
  • The Impact of the Top 3 Strategic Imperatives on the Clinical Diagnostics Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine

Growth Environment

  • Segmentation
  • Growth Environment

Macroeconomic Factors

  • Global Economy Beat Expectations in 2024, Growing at 3.2%
  • Trump 2.0 to Drive Growth Slowdown and Inflationary Pressures
  • Global Growth Slowdown to 2.8%, Avoiding a Recession in 2025; Weaker China to Weigh on Asia Pacific Growth
  • Global Growth Slows to 2.8% in 2025, Recession Averted; Weaker China Expected to Weigh on APAC Outlook
  • Global Macroeconomic Shifts and Resilience Strategies: Tech Integration, R&D, and Agile Production Ecosystems Will Ensure Short-term Resiliency

Impact of US Tariffs

  • US Tariffs - 2025 Analysis
  • US Tariffs - Implications for Key Stakeholders in the Clinical Diagnostics Industry
  • Global Supply Chains Are Being Reshaped by Trade Tariffs, Which Will Drive Decentralization and Open New Growth Opportunities in the Clinical Diagnostics Industry

Revenue Trends, 2025

  • Forecast Considerations
  • Clinical Diagnostics Industry by Segment
  • Revenue Forecast by Subsegment
  • Revenue Forecast by Segment - Centralized Testing
  • Revenue Forecast by Segment - Referral and Peripheral and Decentralized Testing
  • End User Analysis for Centralized, Referral and Peripheral, and Decentralized Testing
  • Revenue Forecast by Region
  • Revenue Forecast Analysis by Region
  • Regional Regulatory Framework and Reimbursement Policy

Competitive Environment

  • Revenue Share
  • Revenue Share Analysis
  • Competitor Matrix
  • Notable Activities

Top 5 Predictions - 2025

  • Prediction 1 - CDx to Drive the Next Era of Precision Medicine, Becoming the Cornerstone of Innovation by 2025
  • Prediction 2 - LIMS Integration to Revolutionize Life Sciences, Driving Data-driven Innovation Beyond $2 Billion
  • Prediction 3 - Multi-omics Diagnostics to Propel a Paradigm Shift in Disease Characterization
  • Prediction 4 - DaaS to Disrupt Traditional Labs and Usher in a New Era of On-demand Testing
  • Prediction 5 - Decentralized Molecular Testing to Redefine Healthcare Access in Emerging Markets, with Global Market Expected to Surpass $24 Billion by 2025

Clinical Diagnostics Outlook

  • 2024 Industry Snapshot

CC&IA - 2025

  • CC&IA Industry Snapshot
  • CC&IA Industry - Companies to Watch

Molecular Diagnostics - 2025

  • Molecular Diagnostics Industry Snapshot
  • Molecular Diagnostics Industry - Companies to Watch

POCT - 2025

  • POCT Industry Snapshot
  • POCT Industry - Companies to Watch

Tissue Diagnostics - 2025

  • Tissue Diagnostics Industry Snapshot
  • Tissue Diagnostics Industry - Companies to Watch

Growth Opportunity Universe

  • Growth Opportunity 1: LIMS for Improved Predictive Analysis
  • Growth Opportunity 2: Companion Diagnostics CDx Expanding Beyond Oncology
  • Growth Opportunity 3: Multiplex POCT for Rapid AMR Antimicrobial Resistance Diagnostics

Conclusions

  • Conclusions and Future Outlook

Next Steps

  • Benefits and Impacts of Growth Opportunities

For more information about this report visit https://www.researchandmarkets.com/r/uzugy

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.